menu
    • menu

    Company profile for EnGeneIC

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EnGeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform. EnGeneIC's lead technology platform, EDV™ utilizes antibody-targeted, bacterially derived, non-living "nanocells" to release high concentrations of chemotherapeutic agents, mole...
    EnGeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform. EnGeneIC's lead technology platform, EDV™ utilizes antibody-targeted, bacterially derived, non-living "nanocells" to release high concentrations of chemotherapeutic agents, molecularly targeted drugs, and RNA-interference molecules directly into targeted tumor cells. In doing so, EDV™ nanocells enable current cancer treatments to be more potent and far less toxic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EnGeneICAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    2/25 Sirius Road (entrance off Mars Road) Lane Cove West -2066
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://engeneic.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/engeneic/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EnGeneIC launches new Australian trial for innovative cancer therapy
    EnGeneIC launches new Australian trial for innovative cancer therapy

    12 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3079706/0/en/EnGeneIC-launches-groundbreaking-new-Australian-trial-for-innovative-cancer-therapy-with-international-trial-site-in-Singapore-to-follow.html

    GLOBENEWSWIRE
    12 May 2025
    Share Share
    Oncologist Daniel Von Hoff Joins EnGeneIC Advisory Board
    Oncologist Daniel Von Hoff Joins EnGeneIC Advisory Board

    01 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//en/news-release/2024/10/01/2956085/0/en/Distinguished-Oncologist-Professor-Daniel-Von-Hoff-joins-the-Scientific-Clinical-Advisory-Board-of-EnGeneIC-Cancer-Therapeutics.html

    GLOBENEWSWIRE
    01 Oct 2024
    Share Share
    EnGeneIC, SingaporeMed Partner For Cancer Treatment Innovation In Asia
    EnGeneIC, SingaporeMed Partner For Cancer Treatment Innovation In Asia

    06 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/07/2895135/0/en/EnGeneIC-and-Singapore-Institute-of-Advanced-Medicine-Holdings-Forge-Strategic-Partnership-to-Revolutionise-Cancer-Treatment-in-Asia.html

    GLOBENEWSWIRE
    06 Jun 2024
    Share Share
    EnGeneIC granted Fast-Track Designation for ANDC Pancreatic Cancer Therapeutic
    EnGeneIC granted Fast-Track Designation for ANDC Pancreatic Cancer Therapeutic

    07 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/08/2792949/0/en/Teladoc-Health-Announces-Employee-Inducement-Awards-under-NYSE-Rule-303A-08.html

    GLOBENEWSWIRE
    07 Dec 2023
    Share Share
    November is Pancreatic Cancer Awareness Month
    November is Pancreatic Cancer Awareness Month

    08 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/08/2775878/0/en/November-is-Pancreatic-Cancer-Awareness-Month.html

    GLOBENEWSWIRE
    08 Nov 2023
    Share Share
    EnGeneIC publishes the COVID-EDV vaccine
    EnGeneIC publishes the COVID-EDV vaccine"s novel mechanism of action

    31 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/31/2598895/0/en/EnGeneIC-publishes-the-COVID-EDV-vaccine-s-novel-mechanism-of-action-in-a-leading-Immunology-journal.html

    GLOBENEWSWIRE
    31 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search